Abstract | BACKGROUND: OBJECTIVE: METHODS: Data on patients with vulvar tumors referred to Fondazione Policlinico Universitario Agostino Gemelli IRCCS between February 2020 and July 2021 were retrospectively analyzed. Patients with a positive reverse transcription polymerase chain reaction in nasopharyngeal swab were considered as positive for SARS-Cov-2. RESULTS: One hundred and ninety-one patients with vulvar cancer were evaluated and scheduled for treatment. The median age was 72 years (range 35-94). Seven (3.7%) patients were diagnosed with SARS-Cov-2 infection: three (42.9%) had their treatment delayed, with no apparent consequences, two (28.6%) had their treatment delayed and later abandoned because of clinical worsening due to oncologic disease progression, and two (28.6%) contracted the infection in the post-operative period and died due to respiratory complications. CONCLUSIONS: In most cases the infection had major clinical implications, being associated with significant delays in oncologic treatments and extremely high mortality when contracted in the post-operative period.
|
Authors | Alex Federico, Simona Maria Fragomeni, Luca Tagliaferri, Linda Stella Guajardo Rios, Valentina Lancellotta, Stefano Gentileschi, Giacomo Corrado, Benedetta Gui, Giuseppe Colloca, Vittoria Rufini, Anna Fagotti, Giovanni Scambia, Giorgia Garganese |
Journal | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
(Int J Gynecol Cancer)
Vol. 32
Issue 2
Pg. 127-132
(02 2022)
ISSN: 1525-1438 [Electronic] England |
PMID | 34903559
(Publication Type: Case Reports, Journal Article)
|
Copyright | © IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. |
Topics |
- Adult
- Aged
- Aged, 80 and over
- COVID-19
(complications)
- Fatal Outcome
- Female
- Humans
- Middle Aged
- Neoplasms, Squamous Cell
(complications, therapy)
- Retrospective Studies
- Time-to-Treatment
- Vulvar Neoplasms
(complications, therapy)
|